Arachidonic acid structure
|
Common Name | Arachidonic acid | ||
---|---|---|---|---|
CAS Number | 506-32-1 | Molecular Weight | 304.467 | |
Density | 0.9±0.1 g/cm3 | Boiling Point | 407.5±0.0 °C at 760 mmHg | |
Molecular Formula | C20H32O2 | Melting Point | −49 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 336.3±18.0 °C |
Use of Arachidonic acidArachidonic acid is an essential fatty acid and a major constituent of biomembranes. |
Name | arachidonic acid |
---|---|
Synonym | More Synonyms |
Description | Arachidonic acid is an essential fatty acid and a major constituent of biomembranes. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vivo | Arachidonic acid (ARA) is converted into various lipid mediators, such as prostaglandin E2 (PGE2), which is involved in the development of rheumatoid arthritis (RA)[1]. |
References |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 407.5±0.0 °C at 760 mmHg |
Melting Point | −49 °C(lit.) |
Molecular Formula | C20H32O2 |
Molecular Weight | 304.467 |
Flash Point | 336.3±18.0 °C |
Exact Mass | 304.240234 |
PSA | 37.30000 |
LogP | 6.91 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.501 |
Water Solubility | PRACTICALLY INSOLUBLE |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US) |
---|---|
Hazard Codes | F |
Risk Phrases | R19 |
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | CE6675000 |
Packaging Group | I; II; III |
Hazard Class | 6.1 |
HS Code | 2916190090 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2916190090 |
---|---|
Summary | 2916190090 unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:6.5%。general tariff:30.0% |
Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells.
J. Nutr. Biochem. 25(12) , 1254-62, (2014) The n-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to enhance the effect of chemotherapeutic drugs in clinical studies in cancer patients an... |
|
Cryopreservation prevents iron-initiated highly unsaturated fatty acid loss during storage of human blood on chromatography paper at -20°C.
J. Nutr. 145(3) , 654-60, (2015) Fingertip prick whole blood collection on chromatography paper is amenable to high-throughput fatty acid (FA) profiling for large clinical and field studies. However, sample storage is problematic bec... |
|
Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.
Clin. Exp. Allergy 44(12) , 1515-24, (2014) Atopic dermatitis is an inflammatory skin disease that is characterized by a reduced skin barrier function, reduced filaggrin (FLG) expression as well as increased colonization by Staphylococcus aureu... |
(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid |
AA |
Immunocytophyte |
eicosatetraenoic acid |
MFCD00004417 |
PUFA 20:4n-6 |
ARACHIDONIC ACID(RG) |
5,8,11,14-Icosatetraenoic Acid |
Arachidonic acid |
Hydrazinecarboselenoamide |
ARA |
5,8,11,14-Eicosatetraenoic Acid |
(5Z,8Z,11Z,14Z)-5,8,11,14-Icosatetraenoic acid |
C20:4 (cis-5,8,11,14) |
20:4n-6 |
5,8,11,14-all-cis-Eicosatetraenoic acid |
5,8,11,14-Eicosatetraenoic acid, (all-Z)- |
5,8,11,14-Eicosatetraenoic acid, (5Z,8Z,11Z,14Z)- |
Arachidonate |
(5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenoic acid |
Arachidonic |
EINECS 208-033-4 |
(all-Z)-5,8,11,14-Eicosatetraenoic acid |